analysts and calls -- ML | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
analysts and calls -- ML

An SI Board Since September 2002

Posts	SubjectMarks	Bans
238	19	0

Emcee: scaram(o)uche	Type: Moderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
13	3 in a row today: #1 Amgen (AMGN; $51.62; C-1-9) The ABC's of the TKT Litig	tom pope	-	12/18/2002
12	from yesterday. wish ML was prompter about posting these things MedImmune (MEDI	tom pope	-	12/17/2002
11	ML is active today Amgen (AMGN, $47.27, C-1-9) Volatility Risk: High 12-Month P	tom pope	-	12/12/2002
10	Today from ML Forest Labs (FRX; $93.48; C-1-9) Update on Meeting with Managemen	tom pope	-	12/12/2002
9	Bravo, Ende! Nice clear call. I have no opinion. I have no clear call. I am	scaram(o)uche	-	12/10/2002
8	ML call re MEDI and Flumist, from yesterday MedImmune (MEDI, $26.21, C-1-9) Pre	tom pope	-	12/10/2002
7	<i>From Buy, to Sell, to Neutral all in the same day. That's a trifec	keokalani'nui	-	12/3/2002
6	more from barron's: Message 18289655	mopgcw	-	12/1/2002
5	RESEARCH ALERT-Merrill downgrades IDEC to <b>"neutral"</b>	Icebrg	-	11/26/2002
4	In addition to BGEN, IDPH was downgraded to neutral ("Zevalin adoption like	tom pope	-	11/26/2002
3	RESEARCH ALERT-Biogen cut to "sell" Tuesday November 26, 8:46 am ET	scaram(o)uche	-	11/26/2002
2	Tom: I just sort of think that the threads should sort of be here, for whatever	scaram(o)uche	-	10/2/2002
1	Just became aware of this thread Rick. The team at ML seems to be : Erich Ende E	tom pope	-	10/1/2002

Go to reply# or date (mm/dd/yy):